复旦张江 (688505)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 103657.21
- Circulating A-Shares(W): 71057.21
- Earnings Per Share(RMB): -0.0200
- Net Assets Per Share(RMB): 2.1786
- Operating Revenue(W RMB): 55107.53
- Total Profit(W RMB): -1613.27
- **Net Profit Attributable to Parent(W RMB) **: -1593.65
- Net Profit Growth Rate(%): -118.43
- Weighted Return on Equity(%): -0.7000
- Operating Cash Flow Per Share(RMB): 0.1020
- Undistributed Profit Per Share(RMB): 0.7889
- Capital Reserve Per Share(RMB): 1.2450
2. Main Business
The main business covers:
- Innovative R&D of biopharmaceuticals
- Manufacturing
- Marketing
3. Company Basic Information
- Company Name: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Listing Date: 2020-06-19
- Industry: Pharmaceutical Manufacturing
- Address: No. 308, Cailun Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai
- Website: https://www.fd-zj.com/
- Company Profile: The company was established through the legal overall change of Fudan Zhangjiang Limited, and is primarily engaged in the innovative R&D, manufacturing, and marketing of biopharmaceuticals.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | New Enterprise II Venture Capital Enterprise | General Legal Person | 15689.29 | 22.08 |
| 2 | Shanghai Pudong Emerging Industry Investment Co., Ltd. | General Legal Person | 656.24 | 0.92 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 364.95 | 0.51 |
5. Concept Sectors
- H-Share
- Gene Concept
- Generic Drug
- Innovative Drug
- Margin Trading & Securities Lending
- University Background
- Proposed Reduction
- Sci-Tech Innovation Board Biotech
- Sci-Tech Innovation Board SOE
- Sci-Tech Innovation 200
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information